Jay Patel
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 16
- COVID-19 Clinical Research Studies 3
-
- Lipid metabolism and disorders 3
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Gregory Y.H. Lip (16 shared papers)Antonio Tello‐Montoliu (2 shared papers)ELIZABETH A. HUGHES (5 shared papers)Elizabeth A. Hughes (9 shared papers)Dorairaj Prabhakaran (4 shared papers)Scott Alexander Lear (2 shared papers)Ian Douglas Caterson (2 shared papers)Mark Woodward (2 shared papers)
- Journals
- The Lancet (10 papers)International Journal of Clinical Practice (6 papers)Journal of Human Hypertension (5 papers)Journal of Internal Medicine (5 papers)The Lancet Rheumatology (5 papers)
- Partner nations
- United KingdomIndiaUnited States
In The Last Decade
Jay Patel
88 papers receiving 15.9k citations
Jay Patel's Hit Papers
Peers
Comparison fields: 5 of 200
- Applied Microbiology and Biotechnology 352
- Molecular Medicine 408
- Endocrinology, Diabetes and Metabolism 1.2k
- Nephrology 318
- Genetics 452
Countries citing papers authored by Jay Patel
This map shows the geographic impact of Jay Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Patel more than expected).
Fields of papers citing papers by Jay Patel
This network shows the impact of papers produced by Jay Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Patel. The network helps show where Jay Patel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2904 |
| 3 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1851 |
| 4 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 5 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1105 |
| 6 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 912 |
| 7 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 680 |
| 8 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 9 | Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 411 |
| 10 | Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 369 |
| 11 | Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 322 |
| 12 | 2008 | 270 | |
| 13 | Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 224 |
| 14 | 2006 | 197 | |
| 15 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 16 | Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 148 |
| 17 | Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 144 |
| 18 | Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 118 |
| 19 | 2023 | 98 | |
| 20 | Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 76 |
About Jay Patel
Jay Patel is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, having authored 99 papers that have together received 16.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Infectious Diseases and Tuberculosis (4 papers), Diet and metabolism studies (3 papers), COVID-19 Clinical Research Studies (3 papers), Lipid metabolism and disorders (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (352 citations), Molecular Medicine (408 citations), Endocrinology, Diabetes and Metabolism (1.2k citations), Nephrology (318 citations) and Genetics (452 citations). Jay Patel has collaborated with scholars based in United Kingdom, India and United States. Frequent co-authors include Gregory Y.H. Lip, Antonio Tello‐Montoliu, ELIZABETH A. HUGHES, Elizabeth A. Hughes, Dorairaj Prabhakaran, Scott Alexander Lear, Ian Douglas Caterson, Mark Woodward, Edward Denis Janus and Rachel Huxley. Their work appears in journals such as The Lancet, International Journal of Clinical Practice, Journal of Human Hypertension, Journal of Internal Medicine and The Lancet Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.